New England Asset Management Inc Amgen Inc Transaction History

New England Asset Management Inc

$726 Million
Q3 2025

A detailed history of New England Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, New England Asset Management Inc holds 21,480 shares of AMGN stock, worth $7.34 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

21,480

Previous 21,375 0.49%

Holding current value

$7.34 Million

Previous $5.97 Million 1.56%

% of portfolio

0.83%

Previous 0.98%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$271.18 - $309.22 $28,473 - $32,468	105 Added 0.49%	21,480 $6.06 Million
Q2 2025 Aug 14, 2025	BUY	$262.28 - $309.85 $20,982 - $24,788	80 Added 0.38%	21,375 $5.97 Million
Q1 2025 May 15, 2025	BUY	$258.59 - $327.36 $504,250 - $638,352	1,950 Added 10.08%	21,295 $6.63 Million
Q4 2024 Feb 14, 2025	BUY	$258.78 - $328.31 $280,776 - $356,216	1,085 Added 5.94%	19,345 $5.04 Million
Q3 2024 Nov 07, 2024	SELL	$309.38 - $337.38 $116,017 - $126,517	-375 Reduced 2.01%	18,260 $5.88 Million
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $56,491 - $68,651	-215 Reduced 1.14%	18,635 $5.82 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $174,765 - $210,964	650 Added 3.57%	18,850 $5.36 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $153,420 - $173,076	600 Added 3.41%	18,200 $5.24 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $360,772 - $447,908	-1,650 Reduced 8.57%	17,600 $4.73 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $2.65 Million - $3.23 Million	11,750 Added 156.67%	19,250 $4.65 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $1.6 Million - $2.04 Million	6,999 Added 1397.01%	7,500 $1.97 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $220,195 - $248,340	-981 Reduced 66.19%	501 $113,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $115,585 - $128,626	501 Added 51.07%	1,482 $361,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $87,708 - $97,028	-400 Reduced 28.96%	981 $237,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $113,361 - $129,732	-570 Reduced 29.22%	1,381 $311,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $208,236 - $243,974	981 Added 101.13%	1,951 $415,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $162,271 - $185,270	970	970 $181,000

Others Institutions Holding AMGN

# of Institutions

3,269

Shares Held

428M

Call Options Held

6.17M

Put Options Held

5.85M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on New England Asset Management Inc with notifications on news.

Account

New England Asset Management Inc Amgen Inc Transaction History